您的位置: 首页 > 农业专利 > 详情页

Quinoline derivatives as PI3 kinase inhibitors
专利权人:
GlaxoSmithKline LLC
发明人:
Steven David Knight,Stanley J. Schmidt
申请号:
US14103968
公开号:
US08785433B2
申请日:
2013.12.12
申请国别(地区):
US
年份:
2014
代理人:
摘要:
Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充